Grauslund, J., Abou Taha, A., Dehghani Molander, L., Kawasaki, R., Mller, S., Hjlund, K., & Stokholm, L., Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes, International Journal of Retina and Vitreous , accepted for publication
However, newer GLP-1 medications, such as tirzepatide, which target both GLP-1 and GIP receptors, may be even more effective for weight loss
Size/volume: 200 ml
Researchers believe the high costs and potential complications may have led participants to stop this medication early
Look for a Copper Peptide serum that targets your specific concerns
All GLP-1 agonists caused reduced fetal growth and decreased weight when used during late gestation and lactation